Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (terbuka di window baru)

CRASH-3 Trial Collaborators

Sumber‎: Lancet 2019;394(10210):1713-23.

Index‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (terbuka di window baru)

Alternatives to allogeneic platelet transfusion. (terbuka di window baru)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sumber‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (terbuka di window baru)

Tranexamic acid: less bleeding and less thrombosis? (terbuka di window baru)

Godier A, Roberts I, Hunt BJ.

Sumber‎: Crit Care 2012;16(3):135.

Index‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (terbuka di window baru)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (terbuka di window baru)

Perel P, Ker K, Morales Uribe CH, Roberts I

Sumber‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Index‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (terbuka di window baru)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (terbuka di window baru)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Sumber‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Index‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (terbuka di window baru)

Antifibrinolytic drugs for acute traumatic injury. (terbuka di window baru)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Sumber‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Index‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (terbuka di window baru)

Use of tranexamic acid to reduce bleeding in burns surgery. (terbuka di window baru)

Tang YM, Chapman TW, Brooks P

Sumber‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Index‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (terbuka di window baru)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (terbuka di window baru)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Sumber‎: Burns. 2022;48(3):522-28.

Index‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (terbuka di window baru)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (terbuka di window baru)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Sumber‎: J Blood Med 2011;2:131-4.

Index‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (terbuka di window baru)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (terbuka di window baru)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Sumber‎: Transfusion 2009;49 Suppl 5:240S-7S.

Index‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (terbuka di window baru)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (terbuka di window baru)

Fries D

Sumber‎: Transfusion 2013;53 Suppl 1:91S-5S.

Index‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (terbuka di window baru)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (terbuka di window baru)

Haan J, Scalea T

Sumber‎: Am Surg 2005;71(5):414-5.

Index‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (terbuka di window baru)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (terbuka di window baru)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Sumber‎: J Trauma 2010;69(3):489-500.

Index‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (terbuka di window baru)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (terbuka di window baru)

Hsia CC, Chin-Yee IH, McAlister VC.

Sumber‎: Ann Surg 2008;248(1):61-8.

Index‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (terbuka di window baru)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (terbuka di window baru)

Johansson PI, Eriksen K, Alsbjørn B

Sumber‎: J Trauma 2006;61(4):1016-8.

Index‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (terbuka di window baru)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (terbuka di window baru)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Sumber‎: ANZ J Surg 2013;83(3):155-60.

Index‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (terbuka di window baru)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (terbuka di window baru)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Sumber‎: Injury 2012;43(9):1409-14.

Index‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (terbuka di window baru)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (terbuka di window baru)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Sumber‎: Injury 2008;39(9):1054-61.

Index‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (terbuka di window baru)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (terbuka di window baru)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Sumber‎: Anesthesiology 2003;98(6):1513-5.

Index‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (terbuka di window baru)

Alternatives to allogeneic platelet transfusion. (terbuka di window baru)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sumber‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (terbuka di window baru)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (terbuka di window baru)

Fries D

Sumber‎: Transfusion 2013;53 Suppl 1:91S-5S.

Index‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (terbuka di window baru)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (terbuka di window baru)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Sumber‎: Thromb Res 2014;134(2):360-8.

Index‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (terbuka di window baru)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (terbuka di window baru)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Sumber‎: Br J Haematol 2013;160(2):228-36.

Index‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (terbuka di window baru)

Strategies to reduce the use of blood products: a European perspective. (terbuka di window baru)

Theusinger OM, Felix C, Spahn DR.

Sumber‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Index‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (terbuka di window baru)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (terbuka di window baru)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Sumber‎: Anesthesiology 2008;109(6):1063-76.

Index‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (terbuka di window baru)

Alternatives to allogeneic platelet transfusion. (terbuka di window baru)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Sumber‎: Br J Haematol 2016;175(3):381-92.

Index‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (terbuka di window baru)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (terbuka di window baru)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Sumber‎: Blood Rev 2014;28(3):95-102.

Index‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (terbuka di window baru)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (terbuka di window baru)

Alperin JB

Sumber‎: JAMA 1987;258(14):1916-9.

Index‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (terbuka di window baru)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (terbuka di window baru)

Crowther MA, McDonald E, Johnston M, Cook D

Sumber‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Index‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (terbuka di window baru)

The use of fibrin sealant in burn operations. (terbuka di window baru)

Foster K

Sumber‎: Surgery 2007;142(4 Suppl):S50-4.

Index‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (terbuka di window baru)

Use of fibrin sealant in thermal injury. (terbuka di window baru)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Sumber‎: J Burn Care Rehabil 1997;18(5):429-34.

Index‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (terbuka di window baru)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (terbuka di window baru)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Sumber‎: Br J Anaesth 2012;109(3):376-81.

Index‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (terbuka di window baru)

Transfusion in trauma: why and how should we change our current practice? (terbuka di window baru)

Theusinger OM, Spahn DR, Ganter MT.

Sumber‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Index‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (terbuka di window baru)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (terbuka di window baru)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Sumber‎: Health Technol Assess 2015;19(58):1-228.

Index‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (terbuka di window baru)